Vikas Dandekar, India Bureau Chief at PharmAsiaNews.com reports that Dr Reddy’s Laboratories is in talks with GlaxoSmithKline Pharmaceuticals for marketing of the Red Heart Pill, a combination drug of Statin, Anti-Hypertensives and Aspirin. Cipla had launched a similar drug branded Starpill in India last week but the Red Heart Pill is still awaiting registration in India, he added.
Click here to watch the video on CNBC
Editor's Note: For those of you who don’t regularly watch CNBC’s India affiliate, you may have missed PharmAsia News' own Vikas Dandekar on previous installments.
